DAYNA LOBUE: Open Payments
NPI 1558830299 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 68 payments from 20 companies in 2025. Trend: 2023 $108 · 2024 $389 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $172 |
| Dexcom, Inc. | 8 | $172 |
| GlaxoSmithKline, LLC. | 8 | $138 |
| Lilly USA, LLC | 10 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Amgen Inc. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| Exact Sciences Corporation | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: Dexcom G6 Transmitter, Wegovy, MOUNJARO, JARDIANCE, TRELEGY ELLIPTA, XIFAXAN, Cologuard Collection Kit, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
